CD274 and neoplasm: In vivo experiments demonstrated a dose-dependent reduction in the quantity of PD-L1 on the tumor surface that was bound to anti-PD-L1 antibodies by PD-L1-EVs, suggesting that PD-L1 on EVs has greater affinity for anti-PD-L1 antibodies than for PD-L1 on the cell surface91.